Zydus Lifesciences Q4 Results 2025 Declared 1% Dip in Profit and Dividend of ₹11 Per Share: Check Key Highlights

Name: Stock Advisory service In India
Brand: univest
Rating: 4.4 (197000 reviews)

Posted by : sachet | Tue May 20 2025

Zydus Lifesciences Q4 Results 2025 Declared 1% Dip in Profit and Dividend of ₹11 Per Share: Check Key Highlights

Zydus Lifesceinces has reported its Q4 results for FY25 with a slight dip in profit by 1% YoY. Following to the decline in profitability, Zydus Lifesciences share price fell 2.94% to hit an intraday low of ₹884.45 per share on 20th May 2025. Investors are cautious about next trigger of Zydus Lifesciences share price and market reactions on its Q4 results for FY25.

Table of Contents

Zydus Lifesciences Q4 Results 2025: Key Highlights

Zydus Lifesciences reported its revenue surge by 18% YoY to reach ₹6,527.90 crore against ₹5,533.80 crore in the Q4FY24.
Zydus Lifesciences declares a slight dip of 1% YoY in the net profit reaching ₹1,171 crore against the poll of ₹1,379.60 crore.
EBITDA of Zydus is estimated at ₹2,126 crore with a 30% YoY increase and higher than the poll of ₹1,996.70 crore.
EBITDA margin of Zyds Lifesciences increased by 310 Basis Points to reach 32.60% against 29.50% of the previous years’ EBITDA margin.

Zydus Lifesciences Share Dividend Declaration

The board of directors at Zydus Lifesciences recommended a final dividend of ₹11 per share which is (1100%) per equity share of ₹1 each face value. However, dividend is subject to the approval of shareholders in the forthcoming annual general meeting.

Zydus Lifesciences Share Performance

Zydus Lifesciences share price is currently trading at ₹884.45 per share tumbling over 2.94% or ₹26.80 on 20th May 2025. The stock has delivered 155.11% returns in the past 5 years and 0.34% of Dividend Yield last year. The 52-week high/low of Zydus Lifesciences share is ₹1,324.30/₹795.00.

Final Thoughts

Zydus Lifesciences has declared an 18% revenue surge and 1% profit fall YoY in its Q4 results 2025. The company has got a recommendation for ₹11 per share dividend by its board of directors. Investors have high confidence in Zydus Lifesciences share for long-term and awaiting for a new positive triggers in the shares.

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.